Investors today don't have anything as simple to use in detecting problems for companies as canaries in the coal mine. However, paying close attention to comments made in the quarterly earnings calls ...

ATSG shareholders will receive $22.50 per share in the all-cash deal. The transaction is expected to close in the first half ...

Big Tech stocks face scrutiny despite mixed earnings. In this piece, we examine which tech stock could be the best bet after ...

Intel stock's improved outlook has mitigated recent selling intensity. Still, I argue why betting on the wrong horse (INTC) ...

Amazon stock is increasingly seen as a reasonable value. While the company has historically traded at negative or ...

For these reasons, I think I would pass on Alphabet for now but continue monitoring the stock as the AI narrative continues ...

SoftBank CEO Masayoshi Son recently told investors that he thinks Nvidia stock is undervalued. Masayoshi Son is one of the most celebrated investors in modern history. As CEO of Japanese holding ...

Google's years-long run as the world's dominant internet search engine has turned Alphabet ( GOOG 0.50%) ( GOOGL 0.40%) into a technology juggernaut worth over $2 trillion today. The stock has ...

Finally, AT&T was the last stock in the last decade to be removed from the Dow as it was ousted in 2015. It has ...

Along with Tesla (NASDAQ: TSLA), billionaire Elon Musk also founded the revolutionary space company SpaceX. The firm made headlines several weeks ago after it was successfully able to recover a ...

Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500 The Ark Innovation and Ark Genomic ETFs turn ten years old. A look at the annual returns ...

(RTTNews) - Arcus Biosciences, Inc. (RCUS), Tuesday announced results from part 1 of ARC-10, evaluating the effects of the combination of Domvanalimab and Zimberelimab versus Zimberelimab or ...